Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: Safety, immunogenicity and persistence of antibody responses
- 2 October 2006
- Vol. 25 (6) , 1055-1063
- https://doi.org/10.1016/j.vaccine.2006.09.060
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Persistence of Antibodies in Children Primed with Two Different Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Hepatitis B, Inactivated Poliovirus and Haemophilus influenzae Type b Vaccines and Evaluation of Booster VaccinationHuman Vaccines, 2006
- Safety and immunogenicity of a combined DTPa–IPV vaccine administered as a booster from 4 years of age: A reviewVaccine, 2006
- Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of ageEuropean Journal of Pediatrics, 2005
- Booster vaccination with hexavalent DTPa-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTPa-IPV/Hib + HBV administered separatelyVaccine, 2005
- Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical modelVaccine, 2004
- Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infantsVaccine, 2004
- Hepatitis B: vaccination programmes in Europe — an updateVaccine, 2001
- Prevention of Poliomyelitis: Recommendations for Use of Only Inactivated Poliovirus Vaccine for Routine ImmunizationPublished by American Academy of Pediatrics (AAP) ,1999
- Safety and Immunogenicity of Haemophilus influenzae‐Tetanus Toxoid Conjugate Vaccine Given Separately or in Combination with a Three‐Component Acellular Pertussis Vaccine Combined with Diphtheria and Tetanus Toxoids and Inactivated Poliovirus Vaccine for the First Four DosesClinical Infectious Diseases, 1999
- Antibody Response and Reactions to Completion of a Four-dose Series with a Two - or Three-component Acellular Pertussis Vaccine Compared to Whole Cell Pertussis VaccineScandinavian Journal of Infectious Diseases, 1996